American Trust’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,600
Closed -$245K 323
2025
Q4
$245K Buy
5,600
+12
+0.2% +$496 0.02% 273
2025
Q3
$231K Buy
5,588
+718
+15% +$28.9K 0.02% 283
2025
Q2
$215K Buy
+4,870
New +$195K 0.02% 271

Other funds holding EXEL

American Trust's EXEL Position: Q1 2026 in Review

American Trust sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 5,600 shares — an estimated $245K sold.

American Trust first reported a position in EXEL in Q2 2025 and held it in 3 quarters. The position peaked at $245K in Q4 2025. 700 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • American Trust reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
  • American Trust sold 5,600 Exelixis shares in Q1 2026, an estimated $245K.
  • American Trust first reported a position in Exelixis in Q2 2025 and held it in 3 quarters.
  • American Trust's Exelixis position peaked at $245K in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.